| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20de9997de8dc4eee6d9906aa8b31cc1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-804
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-884 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001154
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 |
| filingDate |
2019-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80e4d97d04b0b0de5ed0a6953b01e388
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_208e914feab73e59710f655df74e4c5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15d9bcb7f83ad35b2b108e167a88e781
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d15f2cfa2fb38fb8852c00123b0ba4a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86726d35cca4dba2bbf990e693efd215 |
| publicationDate |
2020-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2020081996-A9 |
| titleOfInvention |
Compositions and methods for manufacturing bacteriophage cancer vaccines and uses thereof |
| abstract |
Disclosed herein are methods and compositions for manufacturing nanoparticle bacteriophage-based vaccines that are useful for anti-cancer treatments. Also disclosed herein are methods of using bacteriophage-based vaccines expressing aspartyl (asparaginyl) β-hydroxylase for treating cancer. |
| priorityDate |
2018-10-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |